Scios Natrecor Pharmacoeconomic Study To Address Length Of Stay Concerns
Executive Summary
Scios Natrecor pharmacoeconomic study will address advisory committee concern about a one-day longer hospital stay for Natrecor than for nitroglycerin, CEO Richard Brewer told analysts following the committee meeting May 25.